To the editor, A vast array of in vivo experimental models are utilised within the wound healing field. There remains little agreement as to the optimal in vivo experimental approach to mimic human chronic wounds (Wilhelm et al., 2017) . Moreover, animal models of impaired healing have performed particularly poorly at translating drug based therapies to the clinic over many years, leading many to question their effectiveness (Gordillo et al., 2013) . We have previously shown that the wound type (i.e. incision or excision) and subsequent analysis method will determine the sensitivity, and hence the likelihood of a statistically significant difference being correctly identified using a specific healing model (Ansell et al., 2014) .
When considered alongside our demonstration that rodent hair cycle can significantly alter the speed of repair (Ansell et al., 2011) , careful experimental design of in vivo wound models becomes critical for maximising the probability of achieving statistical significance. Indeed the paucity of new drug based therapies emerging for the treatment of chronic wounds may be, at least in part, due to sub-optimal preclinical models.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Diabetes mellitus (DM) is a major cause of human chronic wounds (Eming et al., 2014) .
Several rodent models of DM are available (Ansell et al., 2012 , Boyko et al., 2017 , Davidson, 1998 however, the Streptozotocin (STZ)-induced DM model is almost exclusively used to model type 1 DM (Goodson and Hung, 1977) . Like other wound models there is an inherent lack of consistency between published STZ-DM studies with variation in animal gender, wound size and wound type, but also in the length of time between DM-induction and subsequent injury (Table 1) . We predict this latter variable to be crucial given that numerous effects of hyperglycaemia can take many weeks to manifest, such as advanced glycation endproduct accumulation (Chen et al., 2009) , or structural features of neuropathy (Biessels et al., 2014) . To our knowledge, a rigorous assessment of the degree of healing impairment in the STZ model linked to time post induction has not been published.
To begin to fill this knowledge gap, we first examined wound healing following STZ-induced DM in male Wistar rats as this gender and strain combination is frequently used ( Table 1) .
We compared healing in rats at 3-(n=6 rats) or 6-weeks (n=4 rats) post-DM induction to nondiabetic (n=6 rats) sham control rats (6mm punch biopsy wound harvested at 5 days postwounding; see supplemental methods for full details), to assess the influence of time postinduction on healing outcome.
We collected wound photographs at day 5 (Figure 1a ), which when assessed revealed a significant delay in healing (larger wound surface area) versus control only in 6-week post-DM induction animals ( Figure 1b ). To confirm this observation we profiled standardised histological wound parameters from tissue sections from the centre of each wound ( Figure   1c ). We found no statistically significant difference in histological wound width ( Figure 1d )
or the area of wound granulation tissue ( Figure 1e ). Taken together, these data suggest that planimetry is a more reliable measure of overall healing delay in the STZ-DM model.
Histological analysis, however, has merits with the parameter of re-epithelialisation demonstrating a statistically significant delay reduction (i.e. delayed wound closure) following 6 weeks of DM (Figure 1f ). Again, there was only a trend towards delayed reepithelialisation in rats 3 weeks post-DM induction. Thus, re-epithelialisation appears to provide a sensitive histological readout for the onset of impaired healing with DM.
The inability to statistically demonstrate any aspect of delayed healing at 3 weeks post-STZ-DM induction suggests that this (or any earlier) time point is insufficient, despite being used frequently in the literature (Table 1) . We do however note a trend towards reduced reepithelialisation at 3 weeks, which might become statistically detectable with increased sample sizes (Table S1 ). Many studies do not confirm whether significantly delayed repair exists with their chosen impaired healing model and sample size (Table 1) . Furthermore, almost one third of studies do not indicate the DM induction timeframe used.
That only some wound parameters are demonstrably altered at 6 weeks post-STZ-DM induction suggests that the rate at which individual repair processes become impaired following loss of blood glucose control differs. To further explore this point we assessed changes in inflammation, collagen deposition and angiogenesis, with time-post STZ-DM induction. We find a strong increase in the number of wound macrophages in the 6 week STZ-DM group (Figure 1g) , with no detectable difference in collagen deposition or angiogenesis (Figure 1h, 1i ). While these data suggest that impairment of angiogenesis and collagen deposition take longer than 6 weeks post-STZ-DM, we cannot exclude our single analysis timepoint (day 5) providing a poor readout for these later phases of repair.
Pain withdrawal time in DM rats only declines 4-6 weeks post STZ administration (Kambiz et al., 2015) , so few wounding studies will examine neuropathic healing. It would be interesting to assess chronic diabetes effects on healing, though this would necessitate use of insulin pellets, which will impact on the rate of healing (Goodson and Hung, 1977) , and would preclude direct comparison to our earlier timepoints.
Our assessment of the literature revealed a strong preference for using male animals (Table   1) , though the rationale for this remains unclear. To assess gender-specific effects on the STZ-DM model we conducted a second experiment comparing 6 weeks post-STZ-DM (n=9) versus non-diabetic (n=8) groups of female rats. Our macroscopic assessment reveals a significant delay after 6 weeks of diabetes, although the magnitude of difference was smaller than in males ( Figure S1A ). We could find no delay to repair by any histological measure in female rats ( Figure S1B-D) . Re-epithelialisation data were surprising given the pronounced delay observed in males (Compare Figure S1d to Figure 1f ). Our data indicate that DM impaired healing is less pronounced in female rats. The underlying cause of this gender dichotomy remains unclear, though it may be related to the effects of sex steroid hormones (Ashcroft et al., 1997 , Gilliver et al., 2009 .
Collectively, these data indicate that numerous published studies have been performed using diabetic animals that display hyperglycaemia, but have not yet established a delayed healing phenotype, rendering the published observations invalid. While some may argue that in longer term post-wound studies rats will develop an impaired healing phenotype over the experimental window, early work showed that the initial wound response is critical for overall healing outcome (Seifter et al., 1981) . Our study employed a small wound to correlate healing efficiency with a point in time, though this will not be the optimal approach for all 
